“Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth”, Nep. Med. J., vol. 3, no. 1, pp. 309–312, May 2020, doi: 10.3126/nmj.v3i1.28726.